Scientia Clinical Research
Chris Stellatos is a seasoned professional in corporate and business development, currently serving as the Director at Scientia Clinical Research since February 2024. With previous experience as the Business Development Director for Marken in Australia and New Zealand, and as the Director of Corporate Development at Southern Star Research, Chris has a strong focus on the biotechnology and medical device sectors. Over a decade of experience as a Business Partner, Consultant, and Advisor has provided Chris with expertise in strategic planning and operations across multiple markets, including Australia, New Zealand, the UK, and Southeast Asia. An educational background in Commerce and Human Resources from Macquarie University, combined with a degree in Molecular Biotechnology and Pharmacology from the University of Sydney, further enhances Chris's capabilities in navigating complex clinical development processes and fostering long-term stakeholder relationships.
This person is not in any teams
Scientia Clinical Research
Scientia Clinical Research is world-class state of the art clinical trials facility with a focus on first-in-human and first-in patient studies as well as the ability to facilitate later phase trials in oncology, haematology, healthy volunteers and across other therapeutic disciplines. We are located in the Bright Alliance Building with the Nelune Comprehensive Cancer Centre and services of the Sydney Children’s Hospital. It is also co-located in a major research precinct with Prince of Wales Hospital, Royal Hospital for Women, UNSW and the Lowy Cancer Research Centre and is thus in a prime position to translate preclinical research into early phase clinical trials to enhance patient care. We have an on-site laboratory and pharmacy and we will be the first facility in Australia to use an electronic real-time study data collection system.